A Proof-of-Concept Study to Correlate Retinal Nerve Fiber Layer Changes in Patients With Multiple Sclerosis Treated With Natalizumab or Interferon Beta 1-a (PRTOECT)
This study has been withdrawn prior to enrollment.
(Sponsor decision to withdraw study at this time.)
Information provided by:
First received: October 7, 2008
Last updated: July 29, 2009
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||June 2010|
|Estimated Primary Completion Date:||August 2009 (Final data collection date for primary outcome measure)|